Arix Bioscience plc announces participation at the 19th Annual Rodman & Renshaw Global Investment Conference in New York City on 10-12 September 2017

8th September 2017

LONDON, 8 September 2017:

Arix Bioscience plc (LSE: ARIX) (“Arix Bioscience”, or “the Company”), a global healthcare and life science company supporting medical innovation, will present at the 19th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC. The conference is being held on 10-12 September 2017 at the Lotte New York Palace Hotel in New York City, and the Arix Bioscience presentation is on 12 September at 10:00am Eastern time / 3:00pm BST.

Jonathan Peacock, Chairman of Arix Bioscience, will provide an overview of the Company’s business during the live presentation and will participate in one-on-one meetings with investors who are registered to attend the conference.

The presentation will be webcast live. To access the webcast, please visit The webcast replay will remain available for 90 days following the live presentation.